Patents by Inventor Masami Nakane
Masami Nakane has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9193286Abstract: A vehicle seat including: a seat component including, a cushion material forming an outer shape of the vehicle seat, a plurality of groove parts formed to the cushion material and intersecting each other, a corner part formed by intersection of the plurality of groove parts, and a skin material covering the cushion material, wherein the skin material covers the cushion material while a portion of the skin material is engaged inside the plurality of groove parts in a pulled state, wherein the cushion material includes a protruding portion protruding from an external portion of the corner part, and wherein the protruding portion covers the external portion of the corner part and shrinks toward the external portion of the corner part by a pressing force of the skin material engaged inside the plurality of groove parts in the pulled state.Type: GrantFiled: June 1, 2012Date of Patent: November 24, 2015Assignee: TOYOTA BOSHOKU KABUSHIKI KAISHAInventors: Sakae Okuyama, Masami Nakane
-
Publication number: 20120306256Abstract: A vehicle seat including: a seat component including, a cushion material forming an outer shape of the vehicle seat, a plurality of groove parts formed to the cushion material and intersecting each other, a corner part formed by intersection of the plurality of groove parts, and a skin material covering the cushion material, wherein the skin material covers the cushion material while a portion of the skin material is engaged inside the plurality of groove parts in a pulled state, wherein the cushion material includes a protruding portion protruding from an external portion of the corner part, and wherein the protruding portion covers the external portion of the corner part and is shrinks toward the external portion of the corner part by a pressing force of the skin material engaged inside the plurality of groove parts in the pulled state.Type: ApplicationFiled: June 1, 2012Publication date: December 6, 2012Applicant: TOYOTA BOSHOKU KABUSHIKI KAISHAInventors: Sakae OKUYAMA, Masami NAKANE
-
Publication number: 20120284974Abstract: An engaging clip is provided, which enables a part of a cover material to be hung and engaged in a hanging recess formed in a cushion pad. The engaging clip includes a chuck part, to which a hanging part attached to the cover material is engaged, and a hook part which is hooked and engaged to an engaging member provided in the hanging recess of the cushion pad. The hook part includes a guide piece and a hook piece. The engaging member is inserted between the guide piece and the hook piece while the both pieces are bent outward so as to widen a gap therebetween, so that the hook piece is hooked and engaged to the engaging member. An end portion of the hook piece at a base side is connected to a side part of the chuck part to be supported in a cantilever manner.Type: ApplicationFiled: May 11, 2012Publication date: November 15, 2012Applicant: TOYOTA BOSHOKU KABUSHIKI KAISHAInventors: Kouta YAMAMOTO, Masami NAKANE
-
Publication number: 20120213880Abstract: A mold for forming a skin-integrated foam article, by setting a planar skin material in a cavity, and foam-molding a foam body in the cavity, so that the foam body adheres integrally to the skin material, is disclosed. The mold has a core mold that is pressed against a surface of a part of the skin material set in the cavity when the core mold is placed in a closed position, and forms a hollow portion that is open to the surface of the part of the skin material, in the foam body. The core mold has a protrusion formed on a pressing face thereof which is pressed against the surface of the part of the skin material, and the protrusion is pressed against the surface of the part of the skin material.Type: ApplicationFiled: February 21, 2012Publication date: August 23, 2012Applicant: TOYOTA BOSHOKU KABUSHIKI KAISHAInventors: Tomoki NII, Masami NAKANE
-
Patent number: 6222038Abstract: Compounds of the formula wherein R1 is methoxy and R2 is selected from the group consisting of methyl, ethyl, isopropyl, sec-butyl and tert-butyl; and the pharmaceutically acceptable salts of such compounds. These compounds are substance P antagonists and useful in the treatment of gastrointestinal disorders, inflammatory disorders, central nervous system disorders and pain.Type: GrantFiled: January 24, 1995Date of Patent: April 24, 2001Inventors: Fumitaka Ito, Hiroshi Kondo, Masami Nakane, John Adams Lowe, III, Terry Jay Rosen, Kaoru Shimada
-
Patent number: 6083943Abstract: A compound of the chemical formula (I) and its pharmaceutically acceptable salt: ##STR1## wherein Y is C.sub.2 -C.sub.4 alkylene; Z is a valence bond or C.sub.1 -C.sub.6 alkylene; R.sup.1 is substituted or unsubstituted aryl (e.g., phenyl and naphthyl) or heteroaryl (e.g., thienyl and furyl); R.sup.2 is hydrogen or C.sub.1 -C.sub.6 alkyl; R.sup.3 is hydrogen, hydroxy or the like; R.sup.4 is substituted or unsubstituted benzyl or the like. Typical examples are (2S*,3S*,4R*,5R*)-4-Carboxy-3-[N-(5-Isopropyl-2-methoxy-benzyl)amino]-5-me thyl-2-phenylpyrrolidine and (2S*,3S*,5S*)-5-Carboxy-3-[N-(2-methoxy-5-trifluoromethoxybenzyl)amino]-2- phenylpiperidine. The novel substituted azaheterocyclecarboxylic acids in this invention have excellent substance P antagonistic activity and are thus useful for the treatment of gastrointestinal disorders, central nervous system disorders, allergy, inflammatory diseases, asthma, pain, emesis or migraine in mammals, especially humans.Type: GrantFiled: March 19, 1999Date of Patent: July 4, 2000Assignee: Pfizer IncInventors: Masaya Ikunaka, Yuji Shishido, Masami Nakane
-
Patent number: 5939433Abstract: Compounds of the formula ##STR1## wherein R.sup.1 is methoxy and R.sup.2 is selected from the group consisting of methyl, ethyl, isopropyl, sec-butyl and tert-butyl; and the pharmaceutically acceptable salts of such compounds.These compounds are substance P antagonists and useful in the treatment of gastrointestinal disorders, inflammatory disorders, central nervous system disorders and pain.Type: GrantFiled: April 30, 1997Date of Patent: August 17, 1999Assignee: Pfizer IncInventors: Fumitaka Ito, Hiroshi Kondo, Masami Nakane, Kaoru Shimada, John Adams Lowe, III, Terry Jay Rosen
-
Patent number: 5886009Abstract: This invention relates to the quinuclidine derivative (2S, 3S)-N-(5-n-propyl-2-methoxyphenyl)methyl-2-diphenylmethyl-1-azabicyclo?2.2 .2!octan-3-amine and its pharmaceutically acceptable salts. These compounds are substance P antagonists and are useful in the treatment of gastrointestinal disorders, inflammatory disorders, central nervous system disorders and pain.Type: GrantFiled: June 19, 1995Date of Patent: March 23, 1999Assignee: Pfizer Inc.Inventors: Fumitaka Ito, Hiroshi Kondo, Masami Nakane, Kaoru Shimada
-
Patent number: 5852038Type: GrantFiled: November 18, 1996Date of Patent: December 22, 1998Assignee: Pfizer IncInventors: Fumitaka Ito, Toshihide Kokura, Masami Nakane, Kunio Satake, Hiroaki Wakabayashi
-
Patent number: 5837711Abstract: Certain novel substituted quinuclidine compounds having the ability to antagonize substance P and having the following formula: ##STR1## wherein Ar.sup.1 and Ar.sup.2 are each, independently, thienyl, phenyl, fluorophenyl, chlorophenyl or bromophenyl;X is --CONR.sup.3 R.sup.4, --CO.sub.2 R.sup.3, --CH.sub.2 OR.sup.3, --CH.sub.2 NR.sup.3 R.sup.4 or --CONR.sup.3 OR.sup.4 ;R.sup.1, R.sup.3 and R.sup.4 are each, independently, hydrogen or alkyl having 1 to 4 carbon atoms;R.sup.Type: GrantFiled: April 28, 1995Date of Patent: November 17, 1998Assignee: Pfizer Inc.Inventors: Fumitaka Ito, Toshihide Kokura, Masami Nakane, Kunio Satake, Hiroaki Wakabayashi
-
Patent number: 5807867Abstract: Compounds of the formula ##STR1## wherein R.sup.1 is methoxy and R.sup.2 is selected from the group consisting of methyl, ethyl, isopropyl, sec-butyl and tert-butyl; and the pharmaceutically acceptable salts of such compounds.These compounds are substance P antagonists and useful in the treatment of gastrointestinal disorders, inflammatory disorders, central nervous system disorders and pain.Type: GrantFiled: May 23, 1994Date of Patent: September 15, 1998Assignee: Pfizer Inc.Inventors: Fumitaka Ito, Hiroshi Kondo, Masami Nakane, Kaoru Shimada, John Adams Lowe, III, Terry Jay Rosen
-
Patent number: 5721255Abstract: The present invention relates to novel substituted benzylamino nitrogen containing non-aromatic heterocycles and, specifically, to compounds of the formula ##STR1## wherein W, R.sup.1, R.sup.2, R.sup.3 and A are as defined in the specification, and to intermediates used in the synthesis of such compounds. The novel compounds of formula I are useful in the treatment of inflammatory and central nervous system disorders, as well as other disorders.Type: GrantFiled: February 15, 1995Date of Patent: February 24, 1998Assignee: Pfizer Inc.Inventors: Harry R. Howard, Masami Nakane, Masaya Ikunaka, Kunio Satake, Terry J. Rosen, John A. Lowe, III, Brian T. O'Neill, Fumitaka Ito
-
Patent number: 5716965Abstract: Compounds of the formula ##STR1## wherein W, Ar.sup.1, Ar.sup.2 and Ar.sup.3 are defined as below; and the pharmaceutically acceptable salts of such compounds.These compounds are substance P antagonists and useful in the treatment of gastrointestinal disorders, inflammatory disorders, central nervous system disorders and pain.Type: GrantFiled: December 20, 1993Date of Patent: February 10, 1998Assignee: Pfizer Inc.Inventors: Fumitaka Ito, Toshihide Kokura, Masami Nakane, Kunio Satake, Hiroaki Wakabayashi
-
Patent number: 5681858Abstract: The present invention provides a novel N-hydroxyurea compound of chemical formula (I) wherein R.sup.1 and R.sup.2 are each independently hydrogen or C.sub.1 -C.sub.4 alkyl; Ar is phenyl or mono-, di- or trisubstituted phenyl; A is a valence bond or a C.sub.1 -C.sub.6 alkylene chain, optionally having one double bond or one triple bond in the chain, and optionally having one or more C.sub.1 -C.sub.4 alkyl groups attached to the chain: X is oxygen or sulfur, n is an integer of 3 to 6; M is hydrogen, pharmaceutically acceptable cation or a metabolically cleavable group: and X and A may be attached at any available position on the ring. These compounds are useful for treatment or alleviation of inflammatory diseases, allergy and cardiovascular diseases in mammals and as the active ingredient in pharmaceutical compositions for treating such conditions.Type: GrantFiled: October 3, 1995Date of Patent: October 28, 1997Assignee: Pfizer Inc.Inventors: Rodney William Stevens, Takashi Mano, Yoshiyuki Okumura, Masami Nakane
-
Patent number: 5590872Abstract: A sheet reversing apparatus which has a take-in path, a reversing path which extends from the take-in path in a substantially same direction, a take-out path which extends from a junction of the take-in path and the reversing path in a substantially perpendicular direction to the extending direction of the reversing path. A sheet is fed from the take-in path to the reversing path, and when the trailing edge of the sheet comes out of the take-in path, the sheet is fed back from the reversing path to the take-out path. In an entrance portion of the reversing path, a first reversing roller which is driven to rotate in a feed-back direction toward the take-in path and a second reversing roller which is capable of coming into contact with and moving away from the first reversing roller are provided.Type: GrantFiled: March 29, 1995Date of Patent: January 7, 1997Assignee: Minolta Co., Ltd.Inventors: Taiichi Oominami, Toshio Sakata, Masayoshi Kuroda, Tomonobu Tamura, Masami Nakane, Kazuhiko Nakatsuka
-
Patent number: 5569662Abstract: Compounds useful in the treatment of inflammatory disorders, central nervous system disorders and other disorders of formula (I) and the pharmaceutically-acceptable salts thereof, wherein X.sup.1 is alkoxy or halosubstituted alkoxy; X.sup.2 is hydrogen, halogen, alkyl, alkenyl, alkynyl, alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, halosubstitued alkyl, halosubstituted alkoxy, alkylamino, dialkylamino, alkylsulfonylamino (which may be substituted), N-alkyl-N-alkylsulfonylamino (which may be substituted), alkanoylamino (which may be substituted) or N-alkyl-N-alkanoylamino (which may be substituted); Ar.sup.1 and Ar.sup.2 are each, independently, thienyl, phenyl, fluorophenyl, chlorophenyl or bromophenyl; A is Y--(CH.sub.2).sub.m --CH(R.sup.2)--(CH.sub.2).sub.n --NR.sup.1 --; R.sup.1 is hydrogen, alkyl, benzyl or --(CH.sub.2).sub.p --Y; R.sup.2 is hydrogen, alkyl (which may be substituted), benzyl, 4-hydroxybenzyl, 3-indolylmethyl or --(CH.sub.2).sub.p --Y; Y is --CN, --CH.sub.Type: GrantFiled: October 3, 1994Date of Patent: October 29, 1996Assignee: Pfizer Inc.Inventors: Kunio Satake, Hiroaki Wakabayashi, Masami Nakane
-
Patent number: 5504095Abstract: Aminobenzosultam derivatives, which are inhibitors of lipoxygenase, having the formula ##STR1## and the pharmaceutically acceptable acid addition salts thereof, wherein Ar is cycloalkyl having five to seven carbon atoms, tetrahydropyranyl, pyridyl, oxazolyl, phenyl or substituted phenyl wherein said substituent is methyl, methoxy, fluoro, chloro or trifluoromethyl; n is an integer of 1 to 3; X is hydrogen, methyl, methoxy, fluoro, chloro or trifluoromethyl; Z is --NH--, --O--, or --CH.sub.2 --; and R.sup.1 is hydrogen or alkyl having one to three carbon atoms.Type: GrantFiled: December 20, 1994Date of Patent: April 2, 1996Assignee: Pfizer Inc.Inventors: Masami Nakane, Kunio Satake, Kazuo Ando, Hiroaki Wakabayashi
-
Patent number: 5464849Abstract: Compounds of formula I ##STR1## or salts thereof, where R is alkyl, phenyl, phenoxy or substituted phenyl and phenoxy; X is S or O; n is an integer of 1 or 2; A is --CH.sub.2 -- or --CH(CH.sub.3)--; and B is hydrogen or methyl, useful as antiallergy and antiinflammatory agents.Type: GrantFiled: October 5, 1994Date of Patent: November 7, 1995Assignee: Pfizer Inc.Inventors: Takashi Mano, Rodney W. Stevens, Masami Nakane
-
Patent number: 5290788Abstract: Alkoxy substituted indole derivatives as inhibitors of lipoxygenase and useful as antiallergy and antiinflammatory agents.Type: GrantFiled: April 21, 1992Date of Patent: March 1, 1994Assignee: Pfizer Inc.Inventors: Rodney W. Stevens, Hiromasa Morita, Masami Nakane
-
Patent number: 5256789Abstract: Compounds having the structure ##STR1## wherein X is nitrogen, oxygen, sulfur or a bond and Z is oxygen or sulfur have been synthesized. These compounds are lipoxygenase inhibitors and are useful as the active agent in pharmaceutical compositions for treating inflammatory conditions in humans and other mammals for which lipoxygenase activity has been implicated.Type: GrantFiled: February 18, 1992Date of Patent: October 26, 1993Assignee: Pfizer Inc.Inventors: Rodney W. Stevens, Takafumi Ikeda, Hiroaki Wakabayashi, Masami Nakane